Pomalidomide/Cyclophosphamide/Dexamethasone in Relapse Refractory Myeloma: Safety Profile in Mexicans

Clinical trial NCT03601624 · UNKNOWN

Trial details

NCT number: NCT03601624
Sponsor: Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse Multiple Myeloma Progression Refractory Multiple Myeloma

Start date: 2018-09-01
Primary completion: 2018-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.